Gts Securities LLC Merck & Co., Inc. Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$111.15 - $128.97 $2.87 Million - $3.33 Million	25,800 Added 26.6%	122,800 $13.9 Million
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $24.2 Million - $26 Million	-195,400 Reduced 66.83%	97,000 $12 Million
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $16.2 Million - $18.9 Million	143,300 Added 96.11%	292,400 $38.6 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $8.53 Million - $9.28 Million	-85,100 Reduced 36.34%	149,100 $16.3 Million
Q3 2023 Nov 15, 2023	BUY	$102.95 - $114.33 $24.1 Million - $26.8 Million	234,200 New	234,200 $24.1 Million

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.